Gemma Biotherapeutics
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Safety, Tolerability and Efficacy of GB221 in Infants With Spinal Muscular Atrophy Type 1 (NCT07070999) | Gemma Biotherapeutics | 2026-01-06 |
| Study of Safety, Tolerability and Efficacy of PBKR03 in Pediatric Subjects With Early Infantile Krabbe Disease (NCT04771416) | Gemma Biotherapeutics | 2022-02-24 |
| Study of Safety, Tolerability and Efficacy of PBGM01 in Pediatric Participants With GM1 Gangliosidosis (NCT04713475) | Gemma Biotherapeutics | 2021-03-17 |
Track Gemma Biotherapeutics automatically
Every clearance here is in the API, with alerts when new ones post.